SynthesisEuropean journal of clinical pharmacology2024

Efficacy and safety of ramucirumab for gastric or gastro-esophageal junction adenocarcinoma: a systematic review and meta-analysis.

Ruiqi Ren et al.PubMed ↗Publisher ↗

No numbers read from the abstract.